Skip to main content
Top
Published in: Journal of Clinical Immunology 6/2006

01-11-2006

Detection of Cellular Immunity to Rabies Antigens in Human Vaccinees

Authors: Susan M. Moore, Melinda J. Wilkerson, Rolan D. Davis, Carol R. Wyatt, Deborah J. Briggs

Published in: Journal of Clinical Immunology | Issue 6/2006

Login to get access

 

A nonradioactive multi-parameter flow cytometry assay was developed to identify antigen-specific lymphocytes in human subjects previously vaccinated against rabies virus and was subsequently compared to the standard tritiated thymidine method. A cell tracking dye, carboxyfluorescein succinimidyl ester, was used in combination with surface label for CD4 and CD8 cells in order to determine the response of lymphocytes to killed rabies virus in an antigen recall assay. The rabies virus-specific lymphocyte response was compared to the humoral immune response in each of ten vaccinated and five non-vaccinated subjects. Lymphocyte responses to rabies virus were observed in all ten vaccinated subjects; some noted as early as 3 days after stimulation while others were not until 7 days after stimulation. There was good agreement between the proliferation index of the CFSE assay and the simulation index of the [3H]thymidine assay (kappa statistic=0.73). An inverse relationship was detected between the level of rabies virus neutralizing antibody (RVNA) and the lymphocyte response to inactivated rabies virus in the vaccinated subjects. The association between cytokines production and level of humoral and cellular response was investigated in four representative subjects. Two vaccinated subjects with high proliferation indices and low RVNA titers produced Th1 type cytokines to rabies virus stimulation, whereas two vaccinated individuals with low proliferation indices and high RVNA titers responses did not produce these cytokines.
Literature
1.
go back to reference Haupt W: Rabies–Risk of exposure and current trends in prevention of human cases. Vaccine 17:1742–1749, 1999PubMedCrossRef Haupt W: Rabies–Risk of exposure and current trends in prevention of human cases. Vaccine 17:1742–1749, 1999PubMedCrossRef
2.
go back to reference Dietzschold B, Morimoto K, Hooper DC: Mechanisms of virus-induced neuronal damage and the clearance of viruses from the CNS. Curr Top Microbiol Immunol 253:145–155, 2001PubMed Dietzschold B, Morimoto K, Hooper DC: Mechanisms of virus-induced neuronal damage and the clearance of viruses from the CNS. Curr Top Microbiol Immunol 253:145–155, 2001PubMed
3.
go back to reference Hooper DC, Sauder C, Scott GS, Dietzschold B, Richt JA: Immunopathology and immunoprotection in CNS virus infections: Mechanisms of virus clearance from the CNS. Curr Top Microbiol Immunol 265:163–182, 2002PubMed Hooper DC, Sauder C, Scott GS, Dietzschold B, Richt JA: Immunopathology and immunoprotection in CNS virus infections: Mechanisms of virus clearance from the CNS. Curr Top Microbiol Immunol 265:163–182, 2002PubMed
4.
go back to reference Kuwert EK, Barsenbach J, Werner J, Marcus I, Scheiermann N, Grosse-Wilde H et al.: Early/high and late/low responders among HDCS vaccinees. In Cell Culture Rabies Vaccines and Their Protective Effect in Man, EK Kuwert, RJ Wiktor, H Koprowski (eds). Geneva, International Green Cross, 1981, pp 160–168 Kuwert EK, Barsenbach J, Werner J, Marcus I, Scheiermann N, Grosse-Wilde H et al.: Early/high and late/low responders among HDCS vaccinees. In Cell Culture Rabies Vaccines and Their Protective Effect in Man, EK Kuwert, RJ Wiktor, H Koprowski (eds). Geneva, International Green Cross, 1981, pp 160–168
5.
go back to reference Strady C, Jaussaud R, Beguinot I, Lienard M, Strady A: Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: Validation of a new booster dose strategy. Vaccine 18:2661–2667, 2000PubMedCrossRef Strady C, Jaussaud R, Beguinot I, Lienard M, Strady A: Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: Validation of a new booster dose strategy. Vaccine 18:2661–2667, 2000PubMedCrossRef
6.
go back to reference Aubert MF: Practical significance of rabies antibodies in cats and dogs. Rev Sci Tech 11:735–760, 1992PubMed Aubert MF: Practical significance of rabies antibodies in cats and dogs. Rev Sci Tech 11:735–760, 1992PubMed
7.
go back to reference Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B: Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol 72:3711–3719, 1998PubMed Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B: Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol 72:3711–3719, 1998PubMed
8.
go back to reference Garenne M, Lafon M: Sexist diseases. Perspect Biol Med 41:176–189, 1998PubMed Garenne M, Lafon M: Sexist diseases. Perspect Biol Med 41:176–189, 1998PubMed
9.
go back to reference Lafon M: Immunology. In Rabies, AC Jackson, WH Wunner (eds). San Diego, CA, Academic Press, 2002, pp 351–371 Lafon M: Immunology. In Rabies, AC Jackson, WH Wunner (eds). San Diego, CA, Academic Press, 2002, pp 351–371
10.
go back to reference Hooper DC: The role of immune responses in the pathogenesis of rabies. J Neurovirol 11:88–92, 2005PubMedCrossRef Hooper DC: The role of immune responses in the pathogenesis of rabies. J Neurovirol 11:88–92, 2005PubMedCrossRef
11.
go back to reference Thraenhart O, Kreuzfelder E, Hillebrandt M, Marcus I, Ramakrishnan K, Fu ZF, et al.: Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clin Immunol Immunopathol 71:287–292, 1994PubMedCrossRef Thraenhart O, Kreuzfelder E, Hillebrandt M, Marcus I, Ramakrishnan K, Fu ZF, et al.: Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clin Immunol Immunopathol 71:287–292, 1994PubMedCrossRef
12.
go back to reference Herzog M, Fritzell C, Lafage M, Montano Hirose JA, Scott-Algara D, Lafon M: T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination. Clin Exp Immunol 85:224–230, 1991PubMedCrossRef Herzog M, Fritzell C, Lafage M, Montano Hirose JA, Scott-Algara D, Lafon M: T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination. Clin Exp Immunol 85:224–230, 1991PubMedCrossRef
13.
go back to reference Fulcher D, Wong S: Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunol Cell Biol 77:559–564, 1999PubMedCrossRef Fulcher D, Wong S: Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunol Cell Biol 77:559–564, 1999PubMedCrossRef
14.
go back to reference Givan AL, Fisher JL, Waugh M, Ernstoff MS, Wallace PK: A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods 230:99–112, 1999PubMedCrossRef Givan AL, Fisher JL, Waugh M, Ernstoff MS, Wallace PK: A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods 230:99–112, 1999PubMedCrossRef
15.
go back to reference Smith JS, Yager PA, Baer GM: A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 48:535–541, 1973PubMed Smith JS, Yager PA, Baer GM: A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 48:535–541, 1973PubMed
16.
go back to reference Habel K: Habel test for potency. In Laboratory Techniques in Rabies, FX Meslin, MM Kaplan, H Koprowski (eds). Geneva, World Health Organization, 1996, pp 369-373 Habel K: Habel test for potency. In Laboratory Techniques in Rabies, FX Meslin, MM Kaplan, H Koprowski (eds). Geneva, World Health Organization, 1996, pp 369-373
17.
go back to reference Centers for Disease Control and Prevention: Recommendations of the Advisory Committee on Immunization Practices (ACIP). 48: 1–21. United States, Morbidity and Mortality Weekly Report, 1999 Centers for Disease Control and Prevention: Recommendations of the Advisory Committee on Immunization Practices (ACIP). 48: 1–21. United States, Morbidity and Mortality Weekly Report, 1999
18.
go back to reference World Health Organization: World Health Organization Expert Committee on Rabies: Eighth Report. 824. Geneva, WHO Press, WHO Technical Report Series, 1992 World Health Organization: World Health Organization Expert Committee on Rabies: Eighth Report. 824. Geneva, WHO Press, WHO Technical Report Series, 1992
19.
go back to reference Altman DG: Practical Statistics for Medical Research. London, Chapman and Hall, 1991 Altman DG: Practical Statistics for Medical Research. London, Chapman and Hall, 1991
20.
go back to reference Esser MT, Marchese RD, Kierstead LS, Tussey LG, Wang F, Chirmule N et al.: Memory T cells and vaccines. Vaccine 21:419–430, 2003PubMedCrossRef Esser MT, Marchese RD, Kierstead LS, Tussey LG, Wang F, Chirmule N et al.: Memory T cells and vaccines. Vaccine 21:419–430, 2003PubMedCrossRef
21.
go back to reference Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D et al.: Evidence for a viral superantigen in humans. Nature 358:507–510, 1992PubMedCrossRef Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D et al.: Evidence for a viral superantigen in humans. Nature 358:507–510, 1992PubMedCrossRef
22.
go back to reference Wells AD, Gudmundsdottir H, Turka LA: Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 100:3173–3183, 1997PubMedCrossRef Wells AD, Gudmundsdottir H, Turka LA: Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 100:3173–3183, 1997PubMedCrossRef
23.
go back to reference Maino VC: Rapid assessment of antigen induced cytokine expression in memory T cells by flow cytometry. Vet Immunol Immunopathol 63:199–207, 1998PubMedCrossRef Maino VC: Rapid assessment of antigen induced cytokine expression in memory T cells by flow cytometry. Vet Immunol Immunopathol 63:199–207, 1998PubMedCrossRef
24.
go back to reference Lagrelius M, Jones P, Franck K, Gaines H: Cytokine detection by multiplex technology useful for assessing antigen specific cytokine profiles and kinetics in whole blood cultured up to seven days. Cytokine 33:156–165, 2006PubMedCrossRef Lagrelius M, Jones P, Franck K, Gaines H: Cytokine detection by multiplex technology useful for assessing antigen specific cytokine profiles and kinetics in whole blood cultured up to seven days. Cytokine 33:156–165, 2006PubMedCrossRef
Metadata
Title
Detection of Cellular Immunity to Rabies Antigens in Human Vaccinees
Authors
Susan M. Moore
Melinda J. Wilkerson
Rolan D. Davis
Carol R. Wyatt
Deborah J. Briggs
Publication date
01-11-2006
Published in
Journal of Clinical Immunology / Issue 6/2006
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-006-9044-0

Other articles of this Issue 6/2006

Journal of Clinical Immunology 6/2006 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.